ART'S-WAY MANUFACTURING CO (ARTW)

US0431681032 - Common Stock

1.95  -0.08 (-3.94%)

After market: 1.94 -0.01 (-0.51%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
24.97M
11.42%		28.4M
13.74%		30.281M
6.62%
EBITDA
YoY % growth
1.13M
136.57%		1.14M
0.88%		2.336M
104.92%
EBIT
YoY % growth
520K
113.30%		330K
-36.54%		1.531M
364.01%
Operating Margin
2.08%1.16%5.06%
EPS
YoY % growth
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 0.05 %
Q3 2022
Q2Q % growth		 0.05
400.00%		%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 5.876M
-27.64%		%
Q2 2024
Q2Q % growth		 12.454M
67.84%		%
Q1 2024
Q2Q % growth		 5.723M
-27.46%		%
Q4 2023
Q2Q % growth		 6.852M
-7.02%		%
Q3 2023
Q2Q % growth		 8.12M
8.56%		%
Q2 2023
Q2Q % growth		 7.42M
24.92%		%
Q1 2023
Q2Q % growth		 7.89M
40.64%		%
Q4 2022
Q2Q % growth		 7.37M
1.52%		%
Q3 2022
Q2Q % growth		 7.48M
13.51%		%
Q2 2022
Q2Q % growth		 5.94M
4.03%		%
Q1 2022
Q2Q % growth		 5.61M
3.89%		%
Q4 2021
Q2Q % growth		 7.26M
32.72%		%
Q3 2021
Q2Q % growth		 6.59M
2.01%		%
Q2 2021
Q2Q % growth		 5.71M
4.77%		%
Q1 2021
Q2Q % growth		 5.4M
7.36%		%
Q4 2020
Q2Q % growth		 5.47M
-27.16%		%
Q3 2020
Q2Q % growth		 6.46M
17.45%		%
Q2 2020
Q2Q % growth		 5.45M
-5.22%		%
Q1 2020
Q2Q % growth		 5.03M
22.09%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A